Kovack Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.2M | Sell |
9,377
-87
| -0.9% | -$88.9K | 0.54% | 30 |
|
|
2026
Q1 | $8.84M | Buy |
9,464
+2,075
| +28% | +$2.1M | 0.47% | 41 |
|
|
2025
Q4 | $7.94M | Buy |
7,389
+3,506
| +90% | +$3.35M | 0.37% | 58 |
|
|
2025
Q3 | $2.96M | Sell |
3,883
-76
| -2% | -$56.6K | 0.28% | 66 |
|
|
2025
Q2 | $3.09M | Sell |
3,959
-626
| -14% | -$486K | 0.3% | 70 |
|
|
2025
Q1 | $3.79M | Sell |
4,585
-837
| -15% | -$696K | 0.4% | 51 |
|
|
2024
Q4 | $4.19M | Buy |
5,422
+466
| +9% | +$386K | 0.41% | 47 |
|
|
2024
Q3 | $4.39M | Buy |
4,956
+440
| +10% | +$396K | 0.47% | 41 |
|
|
2024
Q2 | $4.09M | Sell |
4,516
-144
| -3% | -$115K | 0.45% | 40 |
|
|
2024
Q1 | $3.63M | Sell |
4,660
-91
| -2% | -$64.8K | 0.44% | 42 |
|
|
2023
Q4 | $2.77M | Buy |
4,751
+872
| +22% | +$509K | 0.33% | 59 |
|
|
2023
Q3 | $2.08M | Buy |
3,879
+511
| +15% | +$263K | 0.29% | 71 |
|
|
2023
Q2 | $1.58M | Buy |
3,368
+553
| +20% | +$232K | 0.2% | 102 |
|
|
2023
Q1 | $967K | Sell |
2,815
-100
| -3% | -$33.7K | 0.13% | 155 |
|
|
2022
Q4 | $1.07M | Sell |
2,915
-30
| -1% | -$10.6K | 0.16% | 137 |
|
|
2022
Q3 | $952K | Buy |
+2,945
| New | +$933K | 0.14% | 156 |
|
|
2022
Q2 | – | Sell |
-3,344
| Closed | -$957K | – | 692 |
|
|
2022
Q1 | $957K | Sell |
3,344
-522
| -14% | -$134K | 0.1% | 217 |
|
|
2021
Q4 | $1.07M | Sell |
3,866
-251
| -6% | -$63.6K | 0.1% | 211 |
|
|
2021
Q3 | $951K | Sell |
4,117
-67
| -2% | -$16.5K | 0.1% | 228 |
|
|
2021
Q2 | $960K | Buy |
4,184
+189
| +5% | +$38K | 0.11% | 208 |
|
|
2021
Q1 | $746K | Buy |
3,995
+114
| +3% | +$22.3K | 0.1% | 233 |
|
|
2020
Q4 | $655K | Sell |
3,881
-836
| -18% | -$125K | 0.09% | 228 |
|
|
2020
Q3 | $698K | Buy |
4,717
+189
| +4% | +$29.3K | 0.12% | 181 |
|
|
2020
Q2 | $743K | Buy |
4,528
+523
| +13% | +$80.3K | 0.14% | 156 |
|
|
2020
Q1 | $556K | Buy |
4,005
+147
| +4% | +$20.2K | 0.13% | 173 |
|
|
2019
Q4 | $507K | Sell |
3,858
-238
| -6% | -$27.6K | 0.09% | 245 |
|
|
2019
Q3 | $458K | Sell |
4,096
-116
| -3% | -$12.9K | 0.09% | 249 |
|
|
2019
Q2 | $467K | Sell |
4,212
-371
| -8% | -$43.7K | 0.11% | 218 |
|
|
2019
Q1 | $595K | Sell |
4,583
-583
| -11% | -$70.9K | 0.15% | 168 |
|
|
2018
Q4 | $598K | Buy |
5,166
+896
| +21% | +$100K | 0.17% | 141 |
|
|
2018
Q3 | $458K | Buy |
+4,270
| New | +$427K | 0.12% | 209 |
|
|
2018
Q2 | – | Sell |
-4,163
| Closed | -$322K | – | 491 |
|
|
2018
Q1 | $322K | Buy |
4,163
+271
| +7% | +$21.8K | 0.08% | 298 |
|
|
2017
Q4 | $329K | Buy |
+3,892
| New | +$331K | 0.08% | 281 |
|
|
2017
Q2 | – | Sell |
-2,490
| Closed | -$209K | – | 395 |
|
|
2017
Q1 | $209K | Sell |
2,490
-2,475
| -50% | -$198K | 0.08% | 262 |
|
|
2016
Q4 | $365K | Buy |
+4,965
| New | +$370K | 0.17% | 144 |
|
Other funds holding LLY
SC
ONB
GIM
Kovack Advisors's LLY Position: Q2 2026 in Review
Kovack Advisors reduced its Eli Lilly (LLY) stake by 0.92% in Q2 2026, selling an estimated $88.9K and leaving 9,377 shares worth $11.2M. The position accounts for 0.54% of the portfolio, ranked #30.
Kovack Advisors first reported a position in LLY in Q4 2016 and has held it in 35 quarters since. 1,969 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Kovack Advisors held 9,377 shares of Eli Lilly worth $11.2M as of Q2 2026.
- Kovack Advisors sold 87 Eli Lilly shares in Q2 2026, an estimated $88.9K.
- Eli Lilly made up 0.54% of Kovack Advisors's portfolio in Q2 2026, its #30 holding.
- Kovack Advisors first reported a position in Eli Lilly in Q4 2016 and has held it in 35 quarters since.
- 1,969 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.